Company Name
Changchun GeneScience Pharmaceutical Co., Ltd.
Year of Establishment
1996
Enterprise Size
more than 1000
Annual Turnover(USD)
More than 99,999,999
Company Introduction
Changchun GeneScience Pharmaceutical Co., Ltd. (“GenSci”), founded in 1996. During the past two decades, we have been focused on R&D, manufacturing, commercialization and export of products in the fields of children growth, women’s health, wound healing, anti-aging, and oncology, etc.
We successfully launched a series of somatropin products, including the short-acting lyophilized powder in 1998, liquid formulation in 2005, and long-acting PEG-Somatropin in 2014.
GenSci is travelling on the road of innovative medicines and will bring new hopes to patients...
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,
Website
http://www.gensci-china.com
Milestone
We successfully launched a series of somatropin products, including the short-acting lyophilized powder in 1998, liquid formulation in 2005, and long-acting PEG-Somatropin in 2014.
In 2015, we launched the first China’s Follitropin.